AMN HEALTHCARE SERVICES INC (AMN) Stock Fundamental Analysis
NYSE:AMN - New York Stock Exchange, Inc. - US0017441017 - Common Stock - Currency: USD
Taking everything into account, AMN scores 4 out of 10 in our fundamental rating. AMN was compared to 103 industry peers in the Health Care Providers & Services industry. AMN has only an average score on both its financial health and profitability. AMN has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
AMN had positive earnings in the past year.
AMN had a positive operating cash flow in the past year.
Of the past 5 years AMN 4 years were profitable.
AMN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of AMN (-6.91%) is worse than 72.82% of its industry peers.
AMN has a Return On Equity of -23.13%. This is in the lower half of the industry: AMN underperforms 66.02% of its industry peers.
AMN has a Return On Invested Capital (3.77%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AMN is above the industry average of 9.71%.
The last Return On Invested Capital (3.77%) for AMN is well below the 3 year average (13.14%), which needs to be investigated, but indicates that AMN had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.91% | ||
| ROE | -23.13% | ||
| ROIC | 3.77% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
1.3 Margins
AMN has a Operating Margin (3.24%) which is comparable to the rest of the industry.
AMN's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 30.15%, AMN is in line with its industry, outperforming 55.34% of the companies in the same industry.
AMN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.24% | ||
| PM (TTM) | N/A | ||
| GM | 30.15% |
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
2. Health
2.1 Basic Checks
AMN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for AMN has been increased compared to 1 year ago.
Compared to 5 years ago, AMN has less shares outstanding
The debt/assets ratio for AMN has been reduced compared to a year ago.
2.2 Solvency
AMN has an Altman-Z score of 2.40. This is not the best score and indicates that AMN is in the grey zone with still only limited risk for bankruptcy at the moment.
AMN has a Altman-Z score (2.40) which is comparable to the rest of the industry.
AMN has a debt to FCF ratio of 3.85. This is a good value and a sign of high solvency as AMN would need 3.85 years to pay back of all of its debts.
AMN has a Debt to FCF ratio of 3.85. This is in the better half of the industry: AMN outperforms 72.82% of its industry peers.
AMN has a Debt/Equity ratio of 1.39. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.39, AMN is doing worse than 67.96% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.39 | ||
| Debt/FCF | 3.85 | ||
| Altman-Z | 2.4 |
ROIC/WACC0.51
WACC7.35%
2.3 Liquidity
AMN has a Current Ratio of 1.08. This is a normal value and indicates that AMN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of AMN (1.08) is worse than 69.90% of its industry peers.
A Quick Ratio of 1.08 indicates that AMN should not have too much problems paying its short term obligations.
AMN has a worse Quick ratio (1.08) than 65.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.08 | ||
| Quick Ratio | 1.08 |
3. Growth
3.1 Past
The earnings per share for AMN have decreased strongly by -57.98% in the last year.
AMN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.80% yearly.
The Revenue for AMN has decreased by -18.13% in the past year. This is quite bad
Measured over the past years, AMN shows a small growth in Revenue. The Revenue has been growing by 6.07% on average per year.
EPS 1Y (TTM)-57.98%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-53.61%
Revenue 1Y (TTM)-18.13%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-16%
3.2 Future
The Earnings Per Share is expected to grow by 22.82% on average over the next years. This is a very strong growth
Based on estimates for the next years, AMN will show a small growth in Revenue. The Revenue will grow by 4.40% on average per year.
EPS Next Y-65.33%
EPS Next 2Y-33.74%
EPS Next 3Y-17.8%
EPS Next 5Y22.82%
Revenue Next Year-9.82%
Revenue Next 2Y-4.07%
Revenue Next 3Y-1%
Revenue Next 5Y4.4%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 7.58, which indicates a rather cheap valuation of AMN.
AMN's Price/Earnings ratio is rather cheap when compared to the industry. AMN is cheaper than 97.09% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.30, AMN is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 14.56, the valuation of AMN can be described as correct.
Based on the Price/Forward Earnings ratio, AMN is valued a bit cheaper than 74.76% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of AMN to the average of the S&P500 Index (21.76), we can say AMN is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.58 | ||
| Fwd PE | 14.56 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, AMN is valued cheaper than 86.41% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, AMN is valued cheaply inside the industry as 99.03% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.13 | ||
| EV/EBITDA | 6.83 |
4.3 Compensation for Growth
A cheap valuation may be justified as AMN's earnings are expected to decrease with -17.80% in the coming years.
PEG (NY)N/A
PEG (5Y)9.43
EPS Next 2Y-33.74%
EPS Next 3Y-17.8%
5. Dividend
5.1 Amount
No dividends for AMN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
21.16
-0.94 (-4.25%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners106.39%
Inst Owner Change0%
Ins Owners0.42%
Ins Owner Change4.7%
Market Cap810.00M
Analysts69.23
Price Target27.07 (27.93%)
Short Float %11.52%
Short Ratio5.45
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)84.13%
Min EPS beat(2)52.24%
Max EPS beat(2)116.02%
EPS beat(4)4
Avg EPS beat(4)50.41%
Min EPS beat(4)5.34%
Max EPS beat(4)116.02%
EPS beat(8)8
Avg EPS beat(8)29.43%
EPS beat(12)12
Avg EPS beat(12)22.72%
EPS beat(16)16
Avg EPS beat(16)20.98%
Revenue beat(2)2
Avg Revenue beat(2)3.32%
Min Revenue beat(2)1.88%
Max Revenue beat(2)4.75%
Revenue beat(4)3
Avg Revenue beat(4)1.77%
Min Revenue beat(4)-0.96%
Max Revenue beat(4)4.75%
Revenue beat(8)4
Avg Revenue beat(8)0.76%
Revenue beat(12)8
Avg Revenue beat(12)1.38%
Revenue beat(16)12
Avg Revenue beat(16)2.16%
PT rev (1m)-7.12%
PT rev (3m)-15.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-12.64%
EPS NY rev (1m)13.63%
EPS NY rev (3m)3.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.57%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.41%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.58 | ||
| Fwd PE | 14.56 | ||
| P/S | 0.28 | ||
| P/FCF | 3.13 | ||
| P/OCF | 2.44 | ||
| P/B | 1.13 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.83 |
EPS(TTM)2.79
EY13.19%
EPS(NY)1.45
Fwd EY6.87%
FCF(TTM)6.77
FCFY31.97%
OCF(TTM)8.67
OCFY40.95%
SpS74.52
BVpS18.68
TBVpS-14.22
PEG (NY)N/A
PEG (5Y)9.43
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.91% | ||
| ROE | -23.13% | ||
| ROCE | 5.09% | ||
| ROIC | 3.77% | ||
| ROICexc | 3.89% | ||
| ROICexgc | 13.75% | ||
| OM | 3.24% | ||
| PM (TTM) | N/A | ||
| GM | 30.15% | ||
| FCFM | 9.08% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
ROICexc(3y)13.46%
ROICexc(5y)13.47%
ROICexgc(3y)46.83%
ROICexgc(5y)47.63%
ROCE(3y)17.73%
ROCE(5y)17.46%
ROICexcg growth 3Y-38.44%
ROICexcg growth 5Y-11.09%
ROICexc growth 3Y-36.92%
ROICexc growth 5Y-11.74%
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
F-Score3
Asset Turnover1.19
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.39 | ||
| Debt/FCF | 3.85 | ||
| Debt/EBITDA | 3.81 | ||
| Cap/Depr | 43% | ||
| Cap/Sales | 2.55% | ||
| Interest Coverage | 1.64 | ||
| Cash Conversion | 126.86% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.08 | ||
| Quick Ratio | 1.08 | ||
| Altman-Z | 2.4 |
F-Score3
WACC7.35%
ROIC/WACC0.51
Cap/Depr(3y)57.01%
Cap/Depr(5y)52.87%
Cap/Sales(3y)2.35%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.98%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-53.61%
EPS Next Y-65.33%
EPS Next 2Y-33.74%
EPS Next 3Y-17.8%
EPS Next 5Y22.82%
Revenue 1Y (TTM)-18.13%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-16%
Revenue Next Year-9.82%
Revenue Next 2Y-4.07%
Revenue Next 3Y-1%
Revenue Next 5Y4.4%
EBIT growth 1Y-63.46%
EBIT growth 3Y-38.24%
EBIT growth 5Y-7.5%
EBIT Next Year95.75%
EBIT Next 3Y30.53%
EBIT Next 5YN/A
FCF growth 1Y-37.16%
FCF growth 3Y-1.64%
FCF growth 5Y4.92%
OCF growth 1Y-33.25%
OCF growth 3Y1.61%
OCF growth 5Y7.34%